SEC 13F Intelligence

Managers / Q4 2021 · view latest →

Patient Capital Management, LLC

CIK 0001854794 · ONE SOUTH STREET, SUITE 2101, BALTIMORE, MD, 21202 · 410-454-3130

Reported Value
$347M
Q4 2021
Positions
43
Filings on Record
18
2019–present window
Filed
Feb 14, 2022
original filing

Summary

Patient Capital Management, LLC reported $347M in U.S.-listed holdings across 43 positions for Q4 2021.

Its largest position, GOOGL, represents 3.1% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+27.9%
share of reported value
Largest Position
+3.1%
Alphabet

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $347MQ4 ’21Q1 ’22: $295MQ2 ’22: $226MQ3 ’22: $200MQ3 ’22Q4 ’22: $206MQ1 ’23: $224MQ2 ’23: $1.8BQ2 ’23Q3 ’23: $1.7BQ4 ’23: $1.9BQ1 ’24: $2.1BQ1 ’24Q2 ’24: $1.9BQ3 ’24: $2.0BQ4 ’24: $2.2BQ4 ’24Q1 ’25: $1.9BQ2 ’25: $2.2BQ3 ’25: $2.5BQ3 ’25Q4 ’25: $2.6BQ1 ’26: $2.7Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 76.2%ETP: 9.7%Other: 8.0%ADR: 4.3%MLP: 1.7%
  • Common Stock · 76.2% · $264M
  • ETP · 9.7% · $34M
  • Other · 8.0% · $28M
  • ADR · 4.3% · $15M
  • MLP · 1.7% · $6M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
AMZNAMAZON COM INCNEW+15.2K15.2K+$51M$51M
ISHARES TRNEW+228.0K228.0K+$34M$34M
COINCOINBASE GLOBAL INCNEW+53.0K53.0K+$13M$13M
UBERUBER TECHNOLOGIES INCNEW+259.8K259.8K+$11M$11M
GOOGLALPHABET INCNEW+3.7K3.7K+$11M$11M
METAMETA PLATFORMS INCNEW+31.4K31.4K+$11M$11M
NORWEGIAN CRUISE LINE HLDG LNEW+508.8K508.8K+$11M$11M
DXCDXC TECHNOLOGY CONEW+323.7K323.7K+$10M$10M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2021

38 positions
#IssuerClass% PortfolioValueShares
1GOOGLALPHABET INChistory →CAP STK CL A3.08%$11M3.7K
2METAMETA PLATFORMS INChistory →CL A3.04%$11M31.4K
3NORWEGIAN CRUISE LINE HLDG LSHS3.04%$11M508.8K
4DXCDXC TECHNOLOGY COhistory →COM3.00%$10M323.7K
5DALDELTA AIR LINES INC DELhistory →COM NEW2.74%$9M243.0K
6GMGENERAL MTRS COhistory →COM2.66%$9M157.4K
7OVVOVINTIV INChistory →COM2.63%$9M270.6K
8HWAYEURTIVITY HEALTH INChistory →COM2.62%$9M344.4K
9BABAALIBABA GROUP HLDG LTDhistory →SPONSORED ADS2.61%$9M76.2K
10MATMATTEL INChistory →COM2.51%$9M403.7K
11FTCHQFARFETCH LTDhistory →ORD SH CL A2.49%$9M258.4K
12ADTADT INC DELhistory →COM2.36%$8M974.8K
13BHCBAUSCH HEALTH COS INChistory →COM2.31%$8M290.3K
14FANGDIAMONDBACK ENERGY INChistory →COM2.30%$8M74.0K
15AVID TECHNOLOGY INCCOM2.13%$7M227.3K
16HERBALIFE NUTRITION LTDCOM SHS2.13%$7M180.8K
17TMHCTAYLOR MORRISON HOME CORPhistory →COM2.05%$7M203.6K
18FISVFISERV INChistory →COM1.96%$7M65.6K
19SPLKCHFSPLUNK INChistory →COM1.92%$7M57.7K
20JPMJPMORGAN CHASE & COhistory →COM1.82%$6M39.9K
21UBERUBER TECHNOLOGIES INChistory →COM1.81%$6M149.8K
22TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS1.73%$6M749.9K
23QUOTUSDQUOTIENT TECHNOLOGY INChistory →COM1.72%$6M806.0K
24WW6WW INTL INChistory →COM1.67%$6M358.8K
25ETENERGY TRANSFER L Phistory →COM UT LTD PTN1.65%$6M697.0K
26OMFONEMAIN HLDGS INChistory →COM1.52%$5M105.4K
27VNTVONTIER CORPORATIONhistory →COM1.43%$5M161.8K
28COFCAPITAL ONE FINL CORPhistory →COM1.26%$4M30.1K
29TUPTUPPERWARE BRANDS CORPhistory →COM1.25%$4M283.1K
30AMZNAMAZON COM INChistory →COM1.15%$4M1.2K
31RKTROCKET COS INChistory →COM CL A1.14%$4M282.8K
32BACBK OF AMERICA CORPhistory →COM1.13%$4M87.9K
33SOFISOFI TECHNOLOGIES INChistory →COM0.88%$3M193.8K
34WD5ATRAVEL PLUS LEISURE COhistory →COM0.88%$3M55.4K
35SFIXSTITCH FIX INChistory →COM CL A0.88%$3M160.5K
36KARUNA THERAPEUTICS INCCOM0.72%$3M19.2K
37REALTHE REALREAL INChistory →COM0.58%$2M173.5K
38PGENPRECIGEN INChistory →COM0.32%$1M298.2K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$2.7B40May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$2.6B40Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$2.5B41Oct 30, 202513F-HRchanges · EDGAR ↗
Q2 2025$2.2B40Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$1.9B39May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$2.2B43Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$2.0B41Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$1.9B40Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$2.1B42May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$1.9B43Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$1.7B42Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$1.8B44Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$224M42May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$206M43Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$200M42Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$226M42Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$295M45May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$347M43Feb 14, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.